Overview of Research and Development for Anticancer Drugs - Journal of Cancer Therapy

JCT > Vol.7 No.10, October 2016

Journal of Cancer Therapy

Volume 7, Issue 10 (October 2016)

ISSN Print: 2151-1934 ISSN Online: 2151-1942

Google-based Impact Factor: 0.30 Citations h5-index & Ranking

Overview of Research and Development for Anticancer Drugs ()

HTML XML

Download as PDF (Size: 308KB) PP. 762-772

DOI: 10.4236/jct.2016.710077 2,295 Downloads 7,292 Views Citations

Author(s)

Junjie Xu¹, Wenwei Mao^2,3*

Affiliation(s)

¹Shanghai Jiao Tong University School of Medicine, Shanghai, China.
²Lab of Microbial and Biochemical Pharmaceutical, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China.
³Engineering Research Center of Cell and Therapeutic Antibody, Ministry of Education, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China.

ABSTRACT

Anticancer drugs research and development have been the largest market area in the pharmaceutical industry in terms of the number of project, clinical trials and spending. In the last 10 - 30 years, targeting therapy for cancers has been developed and achieved enormous clinical effectiveness by transforming some previously deadly malignancies into chronically manageable conditions, but cure problem still remains. This mini review outlined the current status of anticancer drugs development and hinted the opinions of how to further increase the accuracy and efficacy of discovery for cancer treatment.

KEYWORDS

Anticancer Drugs, Research and Development, Target Therapy, Phenotype Targeting, Anti-Tumor Immunity

Share and Cite:

Xu, J. and Mao, W. (2016) Overview of Research and Development for Anticancer Drugs. Journal of Cancer Therapy, 7, 762-772. doi: 10.4236/jct.2016.710077.

Cited by

[1]	Chemotherapy delivery time affects treatment outcomes of female patients with diffuse large B cell lymphoma
	JCI insight, 2023

[2]	A radiologist's guide to novel anticancer therapies in the era of precision medicine
	European Journal of …, 2022

[3]	In Silico Molecular Docking & ADME Studies Approach for Designing of New Schiff Base Derivatives of Indomethacin as Both Anti-Inflammatory and Anticancer …
	NeuroQuantology, 2022

[4]	Metal and Metal Oxide Nanoparticles from Mimusops elengi Linn. Extract: Green Synthesis, Antioxidant Activity, and Cytotoxicity
	Sains …, 2022

[5]	Engineered phosphorus dendrimers as powerful non-viral nanoplatforms for gene delivery: a great hope for the future of cancer therapeutics
	Exploration of Targeted …, 2022

[6]	Malaysian herbs as potential natural resources of anticancer drugs: From folklore to discovery
	… -PACIFIC JOURNAL OF …, 2022

[7]	In-silico Molecular Docking & ADME/Pharmacokinetic Prediction Studies of Some New Chalcone & Pyrazole Derivatives from N-acetyl-para-aminophenol …
	NeuroQuantology, 2022

[8]	Apoptosis induction in HeLa cervical cancer cell line by steroidal 16, 17-seco-16, 17a-dinitriles
	Journal of the Serbian …, 2022

[9]	Anticancer drug screening of natural products: In vitro cytotoxicity assays, techniques, and challenges
	Asian Pacific Journal of …, 2022

[10]	α-Amanitin-based Small Format-Drug Conjugates for Prostate Cancer Therapy: Enabling Anti-Tumor Activity by Tuning Pharmacokinetic Properties
	2021

[11]	Alabaş (Brassica oleraceae L. var. gongylodes L.) bitkisi yumrusunun etanol ekstraktının HEPG2 hücreleri üzerinde sergileyeceği sitotoksik, antimetastatik ve …
	2021

[12]	Structure–activity relationship studies on Pd176252 derivatives leading to discovery of novel GRP receptor antagonist with potent anticancer activity
	Medicinal Chemistry …, 2021

[13]	Design, docking, ADMET and PASS prediction studies of novel chromen-4-one derivatives for prospective anti-cancer agent
	2021

[14]	Atividade in vitro da secreção de Lucilia cuprina frente à Leishmania amazonensis, Ttrypanosoma cruzi e linhagens celulares
	2021

[15]	Light-triggered redox activity of GdYVO4: Eu3+ nanoparticles
	2020

[16]	Exploring the Pharmacological Potentials of Biosurfactant Derived from Planococcus maritimus SAMP MCC 3013
	2020

[17]	Dark Reactive Oxygen Species Generation in ReVO4:Eu3+ (Re = Gd, Y) Nanoparticles in Aqueous Solutions
	2020

[18]	Synthesis, characterization, anticancer activity, and molecular docking of some new sugar hydrazone and arylidene derivatives
	2019

[19]	Rapid and sensitive electrochemical detection of anticancer effects of curcumin on human glioblastoma cells
	2019

[20]	Synthesis and anticancer activity of bis-benzo [d][1, 3] dioxol-5-yl thiourea derivatives with molecular docking study
	2019

[21]	In vitro cytotoxic activity assay of bacteria extract derived marine sponge Haliclona fascigera toward Hela, WiDr, T47D, and Vero cell line
	2019

[22]	Achievements in Cancer Research and its Therapeutics in Hundred Years
	2019

[23]	Synthesis and anticancer effects of conjugates of doxorubicin and unsaturated fatty acids (LNA and DHA)
	2019

[24]	Janus-Faced Redox Activity of LnVO4:Eu3+ (Ln = Gd,Y, La) Nanoparticles
	2019

[25]	Selective COX-2 inhibitors as anticancer agents: a patent review (2014-2018)
	2019

[26]	Bisbenzimidazoles: Anticancer Vacuolar (H+)-ATPase Inhibitors
	2019

[27]	Design, Synthesis, and Immunological Evaluation of a Multicomponent Construct Based on a Glycotripeptoid Core Comprising B and T Cell Epitopes and a Toll-like …
	Journal of Medicinal Chemistry, 2018

[28]	Anticancer activity of novel steroidal 6-substituted 4-en-3-one D-seco dinitriles
	Steroids, 2018

[29]	Cytotoxic activity of biosourced astins against malignant pleural mesothelioma cells
	2018

[30]	Combining 2D angiogenesis and 3D osteosarcoma microtissues to improve vascularization
	Experimental Cell Research, 2017

Journals Menu

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Journals Menu

Home

About SCIRP

Service

Policies